PT  - JOURNAL ARTICLE
AU  - Mandell, Brian F.
AU  - Weaver, Arthur L.
TI  - Epidemiology of gout
DP  - 2008 Jul 01
TA  - Cleveland Clinic Journal of Medicine
PG  - S9--S12
VI  - 75
IP  - 7 suppl 5
4099  - http://www.ccjm.org/content/75/7_suppl_5/S9.short
4100  - http://www.ccjm.org/content/75/7_suppl_5/S9.full
SO  - Cleve Clin J Med2008 Jul 01; 75
AB  - The incidence and prevalence of gout are rising, likely as a result of a changing pattern of risk factors. At-risk populations are growing, due to the fact that people are living longer. Longevity and current dietary and lifestyle choices have also contributed to increased rates of co-morbidities associated with hyperuricemia and gout. The use of medications to treat such comorbidities also plays a role in some cases of gout. While dietary and lifestyle modification may be useful as adjunctive measures, such changes do not replace pharmacologic treatments for gout or associated comorbidities.